Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that
have been shown to possess immunomodulatory properties in recent years. Initially met with …

Mesenchymal stromal cells (MSCs) have been extensively tested for the treatment of
numerous clinical conditions and have demonstrated good safety but mixed efficacy …

Mesenchymal stem or stromal cells (MSC) are under investigation as a potential
immunotherapy. MSC are usually administered via intravenous infusion, after which they are …

The mechanisms underlying immunomodulatory ability of mesenchymal stromal cells
(MSCs) remain unknown. Recently, studies suggested that the immunomodulatory activity of …

Graft versus host disease (GvHD) is the clinical condition in which bone marrow-derived
mesenchymal stromal cells (MSCs) have been most frequently studied. In this review, we …

Steroid-refractory acute graft-versus-host disease (SR-aGVHD) following hematopoietic cell
transplantation (HSCT) is associated with poor clinical outcomes. Currently, there are no …

Mesenchymal stem cells (MSC) have been considered the promising candidates for the
regenerative and personalized medicine due to their self-renewal potential, multilineage …

Mesenchymal stem cells (MSC) are studied as a cell therapeutic agent for treatment of
various immune diseases. However, therapy with living culture-expanded cells comes with …

Abstract Evaluation of the immunogenicity of human mesenchymal stem cells (MSCs) in an
allogeneic setting during therapy has been hampered by lack of suitable models due to …

Bone marrow-derived mesenchymal stem cells (MSC) have unique immunomodulatory and
reparative properties beneficial for allotransplantation cellular therapy. The clinical …